Fresenius Medical Care North America (FMCNA), the nation’s leading network of dialysis facilities, today announced the launch of UFComplete, a complete fluid-management program for congestive heart failure (CHF) patients. The program – which combines clinically proven ultrafiltration (UF) therapy with cost-effective home monitoring and education initiatives – will be administered by FMCNA’s highly trained multidisciplinary staff in collaboration with hospitals’ own physicians and nurses.
Each year, nearly 5 million Americans are hospitalized with CHF – a condition in which patients’ weakened hearts move blood through their bodies more slowly than normal, causing excess fluid to build up in the arms, legs, ankles, feet, lungs or other organs. CHF is one of the most common reasons for admission to U.S. hospitals, often requiring lengthy and costly stays, and half of those patients are readmitted within six months of their initial discharge.
UF therapy has been shown to slowly and safely lower patients’ excess salt and water levels when conventional diuretic drug treatments fail. It is supported by more than 60 years of published data and randomized clinical trials, and is endorsed by leading heart failure experts.
FMCNA’s innovative UF therapy program builds upon its industry-leading dialysis expertise and inpatient programs with more than 1,000 hospitals nationwide to provide cost-effective UF treatments that significantly improve patient outcomes, reduce hospital admissions and length of stay, and help hospitals avoid financial penalties and the need for capital expenditures.As part of UFComplete, after patients are discharged, they continue to receive three months of follow-up services including daily electronic weight reporting and 24-hour nurse phone support. Clinicians receive live alerts of patient non-compliance or heart failure symptoms, giving them the opportunity to intervene and treat patients earlier. FMCNA also works with hospital staff on educational programs encouraging patients to avoid salt, exercise regularly and take their medications daily.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV